Multidisciplinary approach in placenta accreta surgical treatment

Baranouskaya E.I.; Voroneckij A.N.

doi:https://doi.org/10.17116/repro202228031120

Close metadata

INTRODUCTION

Effective medical care for patients with placenta accreta spectrum (PAS) is a multi-stage process with radiation diagnostic methods, including magnetic resonance imaging, to verify the diagnosis before delivery, hospitalization of a pregnant woman in an obstetric hospital as part of a multidisciplinary hospital of at least 3 technological levels, surgical treatment with the participation of a multidisciplinary team.

OBJECTIVE

Is to demonstrate the features of surgical treatment of placenta accrete by a multidisciplinary surgical team.

MATERIALS AND METHODS

We searched for publications in the Pubmed database for a narrative review of the organization and current methods of surgical treatment of placenta accreta.

RESULTS

Diagnosed or suspected antenatally, PAS is an indication for surgical treatment. Surgical operation always includes a cesarean section with delivery of the fetus, and after that it is necessary to make any treatment option selected in advance and specified during laparotomy: 1) hysterectomy immediately after delivery of the fetus without trying to separate the placenta; 2) after delivery of the fetus without placenta, suturing of the uterine incision with the remaining attached placenta in the uterus for subsequent conservative management; 3) after delivery of the fetus, resection of the uterine wall with placenta and reconstruction of the uterus; 4) delayed hysterectomy with the remaining placenta in the uterus. High risk of placenta invasion into the bladder, parametrium is an indication for diagnostic cystoscopy, placement of a ureteral stent before surgery. For caesarean section, 28.6% of patients with PA undergo bladder and/or ureteral surgery. PAS surgery usually has massive bleeding. An important strategy for reducing bleeding is to perform short-term and invertible pelvic ischemia. For this purpose, balloon occlusion of the common iliac, internal iliac arteries, aorta or uterine artery embolization are used. Conservative treatment with the remaining uterus requires a long-term hospital stay with surgical care available twenty-four hours.

CONCLUSIONS

Prenatal diagnosis of placenta accreta with specification of the depth of placenta ingrowth, timely organization of medical care, high qualification and coordinated work of the surgical team prevent massive blood loss and surgical complications.

Keywords:

bleeding

arterial embolization

balloon occlusion

placenta accreta

hysterectomy

Authors:

Baranouskaya E.I.

Belarusian State Medical University

Voroneckij A.N.

Belarusian State Medical University

Received:

01.02.2021

Accepted:

16.05.2022

Close metadata

References:

Colmorn LB, Petersen KB, Jakobsson M, Lindqvist PG, Klungsoyr K, Källen K, Bjarnadottir RI, Tapper AM, Børdahl PE, Gottvall K, Thurn L, Gissler M, Krebs L, Langhoff-Roos J. The Nordic Obstetric Surveillance Study: a study of complete uterine rupture, abnormally invasive placenta, peripartum hysterectomy, and severe blood loss at delivery. Acta Obstetricia et Gynecologica Scandinavica. 2015;94(7):734-744. https://doi.org/10.1111/aogs.12639
Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. American Journal of Obstetrics and Gynecology. 2005;192(5):1458-1461. https://doi.org/10.1016/j.ajog.2004.12.074
Filippi V, Chou D, Ronsmans C, Graham W, Say L. Levels and Causes of Maternal Mortality and Morbidity. Chapter 3. In: Black RE, Laxminarayan R, Temmerman M, Walker N, eds. Reproductive, Maternal, Newborn, and Child Health: Disease Control Priorities, Third Edition (Volume 2). Washington (DC): The International Bank for Reconstruction and Development/The World Bank; 2016;51-70. https://doi.org/10.1596/978-1-4648-0348-2_ch3
Thurn L, Lindqvist PG, Jakobsson M, Colmorn LB, Klungsoyr K, Bjarnadóttir RI, Tapper AM, Børdahl PE, Gottvall K, Petersen KB, Krebs L, Gissler M, Langhoff-Roos J, Källen K. Abnormally invasive placenta-prevalence, risk factors and antenatal suspicion: results from a large population-based pregnancy cohort study in the Nordic countries. BJOG. 2016;123(8):1348-1355. https://doi.org/10.1111/1471-0528.13547
Fitzpatrick KE, Sellers S, Spark P, Kurinczuk JJ, Brocklehurst P, Knight M. The management and outcomes of placenta accreta, increta, and percreta in the UK: a population-based descriptive study. BJOG. 2014;121(1):62-71. https://doi.org/10.1111/1471-0528.12405
Bailit JL, Grobman WA, Rice MM, Reddy UM, Wapner RJ, Varner MW, Leveno KJ, Iams JD, Tita ATN, Saade G, Rouse DJ, Blackwell SC; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network. Morbidly adherent placenta treatments and outcomes. Obstetrics and Gynecology. 2015;125(3):683-689. https://doi.org/10.1097/AOG.0000000000000680
Cook JR, Jarvis S, Knight M, Dhanjal MK. Multiple repeat caesarean section in the UK: incidence and consequences to mother and child. A national, prospective, cohort study. BJOG. 2013;120(1):85-91. https://doi.org/10.1111/1471-0528.12010
Pomortsev AV, Khudorozhkova ED, Matosyan MA, Makukhina VV, Nosulya IG. Radiological diagnostic of placenta accrete in pregnant women with cesarean scar. Kubanskij nauchnyj medicinskij vestnik. 2018;25(3):97-106. (In Russ.). https://doi.org/10.25207/1608-6228-2018-25-3-97-106
Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009;116(5):648-654. https://doi.org/10.1111/j.1471-0528.2008.02037.x
Lu T, Pu H, Li KD, Mei J, Huang MW, Wang SY. Can introvoxel incoherent motion MRI be used to differentiate patients with placenta accreta spectrum disorders? BMC Pregnancy and Childbirth. 2019;19(1):531. https://doi.org/10.1186/s12884-019-2676-x
Volochovič J, Ramašauskaitė D, Šimkevičiūtė R. Antenatal diagnostic aspects of placenta percreta and its influence on the perinatal outcome: a clinical case and literature review. Acta Medica Lituanica. 2016;23(4):219-226. https://doi.org/10.6001/actamedica.v23i4.3423
Murji A, Kingdom J. Placenta Percreta Involving Maternal Bladder. The New England Journal of Medicine. 2019;381(7):e12. https://doi.org/10.1056/NEJMicm1900978
Norris BL, Everaerts W, Posma E, Murphy DG, Umstad MP, Costello AJ, Wrede CD, Kearsley J. The urologist’s role in multidisciplinary management of placenta percreta. BJU International. 2016;117(6):961-965. https://doi.org/10.1111/bju.13332
Shamshirsaz AA, Fox KA, Salmanian B, Diaz-Arrastia CR, Lee W, Baker BW, Ballas J, Chen Q, Van Veen TR, Javadian P, Sangi-Haghpeykar H, Zacharias N, Welty S, Cassady CI, Moaddab A, Popek EJ, Hui SK, Teruya J, Bandi V, Coburn M, Cunningham T, Martin SR, Belfort MA. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. American Journal of Obstetrics and Gynecology. 2015;212(2): 218.e1-218.e2189. https://doi.org/10.1016/j.ajog.2014.08.019
Jauniaux E, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S, Jurkovic D, Kayem G, Kingdom J, Silver R, Sentilhes L; Royal College of Obstetricians and Gynaecologists. Placenta Praevia and Placenta accreta: Diagnosis and Management: Green-top Guideline No. 27a. BJOG. 2019;126(1):e1-e48. https://doi.org/10.1111/1471-0528.15306
Goh WA, Zalud I. Placenta accreta: diagnosis, management and the molecular biology of the morbidly adherent placenta. The Journal of Maternal-Fetal and Neonatal Medicine. 2016;29(11):1795-1800. https://doi.org/10.3109/14767058.2015.1064103
Zosmer N, Fuller J, Shaikh H, Johns J, Ross JA. Natural history of early first-trimester pregnancies implanted in Cesarean scars. Ultrasound in Obstetrics and Gynecology. 2015;46(3):367-375. https://doi.org/10.1002/uog.14775
Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF, Moore TR, Resnik R. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstetrics and Gynecology. 2010;115(1):65-69. https://doi.org/10.1097/AOG.0b013e3181c4f12a
Bowman ZS, Eller AG, Kennedy AM, Richards DS, Winter TC 3rd, Woodward PJ, Silver RM. Accuracy of ultrasound for the prediction of placenta accreta. American Journal of Obstetrics and Gynecology. 2014;211(2):177.e1-177.e1777. https://doi.org/10.1016/j.ajog.2014.03.029
Pagani G, Cali G, Acharya G, Trisch IT, Palacios-Jaraquemada J, Familiari A, Buca D, Manzoli L, Flacco ME, Fanfani F, Liberati M, Scambia G, D’antonio F. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstetricia et Gynecologica Scandinavica. 2018;97(1):25-37. https://doi.org/10.1111/aogs.13238
Collins SL, Ashcroft A, Braun T, Calda P, Langhoff-Roos J, Morel O, Stefanovic V, Tutschek B, Chantraine F; European Working Group on Abnormally Invasive Placenta (EW-AIP). Proposal for standardized ultrasound descriptors of abnormally invasive placenta (AIP). Ultrasound in Obstetrics and Gynecology. 2016;47(3):271-275. https://doi.org/10.1002/uog.14952
Melcer Y, Jauniaux E, Maymon S, Tsviban A, Pekar-Zlotin M, Betser M, Maymon R. Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. American Journal of Obstetrics and Gynecology. 2018; 218(4):443.e1-443.e8. https://doi.org/10.1016/j.ajog.2018.01.017
Kumar I, Verma A, Ojha R, Shukla RC, Jain M, Srivastava A. Invasive placental disorders: a prospective US and MRI comparative analysis. Acta Radiologica. 2017;58(1):121-128. https://doi.org/10.1177/0284185116638567
Seoud MA, Nasr R, Berjawi GA, Zaatari GS, Seoud TM, Shatila AS, Mirza FG. Placenta accreta: Elective versus emergent delivery as a major predictor of blood loss. Journal of Neonatal-Perinatal Medicine. 2017;10(1):9-15. https://doi.org/10.3233/NPM-1622
Esakoff TF, Handler SJ, Granados JM, Caughey AB. PAMUS: placenta accreta management across the United States. The Journal of Maternal-Fetal and Neonatal Medicine. 2012;25(6):761-765. https://doi.org/10.3109/14767058.2011.598585
D’Souza DL, Kingdom JC, Amsalem H, Beecroft JR, Windrim RC, Kachura JR. Conservative Management of Invasive Placenta Using Combined Prophylactic Internal Iliac Artery Balloon Occlusion and Immediate Postoperative Uterine Artery Embolization. Canadian Association of Radiologists Journa. 2015;66(2):179-184. https://doi.org/10.1016/j.carj.2014.08.002
Takahashi H, Ohkuchi A, Usui R, Suzuki H, Baba Y, Matsubara S. Factors Contributing to Massive Blood Loss on Peripartum Hysterectomy for Abnormally Invasive Placenta: Who Bleeds More? Obstetrics and Gynecology International. 2016;2016:5349063. https://doi.org/10.1155/2016/5349063
Sentilhes L, Kayem G, Chandraharan E, Palacios-Jaraquemada J, Jauniaux E; FIGO Placenta accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management. International Journal of Gynaecology and Obstetrics. 2018;140(3):291-298. https://doi.org/10.1002/ijgo.12410
Pan XY, Wang YP, Zheng Z, Tian Y, Hu YY, Han SH. A Marked Increase in Obstetric Hysterectomy for Placenta accreta. Chinese Medical Journal. 2015;128(16):2189-2193. https://doi.org/10.4103/0366-6999.162508
Chevalier G, Devisme L, Coulon C. [Placenta accreta spectrum disorder: Management and morbidity in a French type-3 maternity]. Gynecologie, Obstetrique, Fertilite and Senologie. 2020;48(6):500-505. https://doi.org/10.1016/j.gofs.2020.03.010
Zuckerwise LC, Craig AM, Newton JM, Zhao S, Bennett KA, Crispens MA. Outcomes following a clinical algorithm allowing for delayed hysterectomy in the management of severe placenta accreta spectrum. American Journal of Obstetrics and Gynecology. 2020; 222(2):179.e1-179.e9. https://doi.org/10.1016/j.ajog.2019.08.035
Palacios-Jaraquemada JM, Fiorillo A, Hamer J, Martínez M, Bruno C. Placenta accreta spectrum: a hysterectomy can be prevented in almost 80% of cases using a resective-reconstructive technique. The Journal of Maternal-Fetal and Neonatal Medicine. 2022;35(2): 275-282. https://doi.org/10.1080/14767058.2020.1716715 33
Savel’eva GM, Kurcer MA, Breslav IYu, Latyshkevich OA, Grigor’yan AM, Shtabnickij AM, Panina OB, Sichinava LG, Evteev VB, Spiridonov DS. Development and implementation in practice of organ-preserving operations for the ingrowth of the placenta previa in patients with a scar on the uterus. Problemy social’noj gigieny, zdravoohraneniya i istorii mediciny. 2019;27(S):693-698. (In Russ.). https://doi.org/10.32687/0869-866X-2019-27-si1-693-698
Rupley DM, Tergas AI, Palmerola KL, Burke WM. Robotically assisted delayed total laparoscopic hysterectomy for placenta percreta. Gynecologic Oncology Reports. 2016;17:53-55. https://doi.org/10.1016/j.gore.2016.05.009
Allen L, Jauniaux E, Hobson S, Papillon-Smith J, Belfort MA; FIGO Placenta accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: Nonconservative surgical management. International Journal of Gynaecology and Obstetrics. 2018;140(3):281-290. https://doi.org/10.1002/ijgo.12409
Smith DD, Perez-Delboy A, Burke WM, Tergas AI. Buttock Necrosis after Uterine Artery Embolization for Delayed Hysterectomy in Placenta Percreta. Case Reports in Obstetrics and Gynecology. 2016;2016:6921280. https://doi.org/10.1155/2016/6921280
Özcan HÇ, Balat Ö, Uğur MG, Sucu S, Tepe NB, Kazaz TG. Use of Bladder Filling to Prevent Urinary System Complications in the Management of Placenta Percreta: a Randomized Prospective Study. Geburtshilfe und Frauenheilkunde. 018;78(2):173-178. https://doi.org/10.1055/s-0044-100039
Mehrabadi A, Hutcheon JA, Liu S, Bartholomew S, Kramer MS, Liston RM, Joseph KS; Maternal Health Study Group of the Canadian Perinatal Surveillance System (Public Health Agency of Canada). Contribution of placenta accreta to the incidence of postpartum hemorrhage and severe postpartum hemorrhage. Obstetrics and Gynecology. 2015;125(4):814-821. https://doi.org/10.1097/AOG.0000000000000722
Mei Y, Zhao H, Zhou H, Jing H, Lin Y. Comparison of infrarenal aortic balloon occlusion with internal iliac artery balloon occlusion for patients with placenta accreta. BMC Pregnancy and Childbirth. 2019;19(1):147. https://doi.org/10.1186/s12884-019-2303-x
Peng W, Shen L, Wang S, Wang H. Retrospective analysis of 586 cases of placenta previa and accreta. Journal of Obstetrics and Gynaecology. 2020;40(5):609-613. https://doi.org/10.1080/01443615.2019.1634019
Sun W, Duan S, Xin G, Xiao J, Hong F, Hong H, Wu Y, Xu Y. Safety and efficacy of preoperative abdominal Aortic balloon occlusion in placenta increta and/or percreta. The Journal of Surgical Research. 2018;222:75-84. https://doi.org/10.1016/j.jss.2017.10.002
Greer JW, Flanagan C, Bhavaraju A, Davis B, Kimbrough MK, Privratsky AK, Robertson R, Taylor JR, Sexton KW, Beck WC. Right external iliac artery thrombus following the use of resuscitative endovascular balloonocclusion of the aorta for placenta accreta. Journal of Surgical Case Reports. 2018;2018(11):rjy313. https://doi.org/10.1093/jscr/rjy313
Chodraui-Filho SF, Monsignore LM, Freitas RK, Nakiri GS, de Carvalho Cavalli R, Duarte G, Abud DG. Can the combination of internal iliac temporary occlusion and uterine artery embolization reduce bleeding and the need for intraoperative blood transfusion in cases of invasive placentation? Clinics. 2019;74:e946. https://doi.org/10.6061/clinics/2019/e946
Chou MM, Kung HF, Hwang JI, Chen WC, Tseng JJ. Temporary prophylactic intravascular balloon occlusion of the common iliac arteries before cesarean hysterectomy for controlling operative blood loss in abnormal placentation. Taiwanese Journal of Obstetrics and Gynecology. 2015;54(5):493-498. https://doi.org/10.1016/j.tjog.2014.03.013
Zanati J, Resch B, Roman H, Brabant G, Sentilhes L, Verspyck E, Henriet E, Sergent F, Houzé de L’aulnoit D, Marpeau L, Clavier E. [Buttock necrosis after subtotal hysterectomy, bilateral internal iliac arteries ligature and pelvic embolization for control of severe post-partum haemorrhage]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction. 2010;39(1):57-60. https://doi.org/10.1016/j.jgyn.2009.06.009
Palacios-Jaraquemada JM. Buttock necrosis and paraplegia after bilateral internal iliac artery embolization for postpartum hemorrhage. Obstetrics and Gynecology. 2012;120(5):1210. https://doi.org/10.1097/aog.0b013e318271f931
Matsumura Y, Matsumoto J, Kondo H, Idoguchi K, Ishida T, Kon Y, Tomita K, Ishida K, Hirose T, Umakoshi K, Funabiki T; DIRECT-IABO Investigators. Fewer REBOA complications with smaller devices and partial occlusion: evidence from a multicentre registry in Japan. Emergency Medicine Journal: EMJ. 2017;34(12): 793-799. https://doi.org/10.1136/emermed-2016-206383
Zhang N, Lou WH, Zhang XB, Fu JN, Chen YY, Zhuang ZG, Lin JH. Vascular complications following prophylactic balloon occlusion of the internal iliac arteries resolved by successful interventional thrombolysis in a patient with morbidly adherent placenta. Journal of Zhejiang University. Science. B. 2017;18(3):272-276. https://doi.org/10.1631/jzus.B1600315